Improving mRNA Stability Through Enhanced Circular RNA CMC Processes for Scalable Manufacturing
Time: 4:20 pm
day: Day One
Details:
- How to leverage the first circular mRNA IND approval to refine stabilisation techniques in line with regulatory requirement to achieve approvals with novel modalities?
- How to adapt current mRNA stabilization techniques to meet the unique requirements of circular RNA, ensuring seamless stabilisation into therapeutic pipelines for increased patient use?
- How to streamline circular RNA production processes, addressing stability challenges while maintaining cost efficiency and quality at GMP standards?
